TotalMarketCap

Verastem

VSTMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.154 B

$9.51 -3.50%

Close of 6 Nov 2026

As of 6 Nov 2026, Verastem (VSTM) has a market capitalization of $1.15B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$30.9M

#2857 by revenue

Earnings

-$209.5M

Loss-making

Shares outstanding

126,014,804

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #139Avalyn PharmaAVLN$1.18B
  2. #140Amphastar PharmaceuticalsAMPH$1.18B
  3. #141VerastemVSTM$1.15B
  4. #142COMPASS PathwaysCMPS$1.11B
  5. #143Seaport TherapeuticsSPTX$1.09B

What if Verastem were worth as much as…

Open the what-if tool →

Gold $28.2T

$232,557.07

Per share 24,467× higher

Bitcoin $1.53T

$12,583.26

Per share 1,324× higher

Apple $5.02T

$41,309.66

Per share 4,346× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Verastem are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.